TransMedics Group Inc (TMDX)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	441,540	401,090	358,759	296,919	241,623	191,824	151,077	119,133	93,459	71,752	51,439	39,089	30,262	28,221	29,942	25,162	25,639	24,069	24,183	26,458
Property, plant and equipment	US$ in thousands	—	—	—	—	—	—	26,894	19,161	24,353	18,472	16,177	12,044	15,688	5,063	4,954	4,734	4,754	4,690	4,404	4,713
Fixed asset turnover		—	—	—	—	—	—	5.62	6.22	3.84	3.88	3.18	3.25	1.93	5.57	6.04	5.32	5.39	5.13	5.49	5.61

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $441,540K ÷ $—K
= —

The fixed asset turnover ratio for TransMedics Group Inc shows variations over the years. The ratio generally measures how efficiently the company is generating revenue from its investment in fixed assets.

From March 2020 to December 2021, the fixed asset turnover consistently ranged between 5.13 and 6.04, indicating that the company was effectively utilizing its fixed assets to generate sales revenue. However, there was a significant drop in this ratio to 1.93 by December 2021, suggesting a potential decline in the efficiency of asset utilization.

Subsequently, the ratio gradually increased from March 2022 to March 2023, reaching a peak of 6.22, which could signify improved efficiency in utilizing fixed assets to generate revenue. However, the ratio decreased thereafter to 3.84 by December 2022, which might indicate a potential decline in asset productivity.

The ratios for the latter part of 2023 and beyond are not available. It would be necessary to monitor future data to assess whether the company is able to maintain or improve its efficiency in generating revenue from fixed assets.